A detailed history of Gamma Investing LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Gamma Investing LLC holds 623 shares of BNTX stock, worth $62,125. This represents 0.01% of its overall portfolio holdings.

Number of Shares
623
Previous 512 21.68%
Holding current value
$62,125
Previous $41.1 Million 79.84%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$78.36 - $124.66 $8,697 - $13,837
111 Added 21.68%
623 $74 Million
Q2 2024

Jul 02, 2024

BUY
$80.36 - $102.87 $19,125 - $24,483
238 Added 86.86%
512 $41.1 Million
Q1 2024

Apr 05, 2024

BUY
$88.96 - $112.35 $13,343 - $16,852
150 Added 120.97%
274 $25.3 Million
Q4 2023

Feb 01, 2024

BUY
$90.91 - $112.75 $11,272 - $13,981
124 New
124 $11.8 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.